Equillium Statistics
Total Valuation
Equillium has a market cap or net worth of $119.84 million. The enterprise value is $63.26 million.
| Market Cap | 119.84M |
| Enterprise Value | 63.26M |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Equillium has 63.41 million shares outstanding. The number of shares has increased by 157.46% in one year.
| Current Share Class | 63.41M |
| Shares Outstanding | 63.41M |
| Shares Change (YoY) | +157.46% |
| Shares Change (QoQ) | +16.13% |
| Owned by Insiders (%) | 10.22% |
| Owned by Institutions (%) | 41.84% |
| Float | 36.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.10 |
| P/TBV Ratio | 2.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.40, with a Debt / Equity ratio of 0.01.
| Current Ratio | 23.40 |
| Quick Ratio | 23.07 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -58.98% and return on invested capital (ROIC) is -38.97%.
| Return on Equity (ROE) | -58.98% |
| Return on Assets (ROA) | -33.95% |
| Return on Invested Capital (ROIC) | -38.97% |
| Return on Capital Employed (ROCE) | -34.35% |
| Weighted Average Cost of Capital (WACC) | 14.10% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.20M |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.95% in the last 52 weeks. The beta is 1.80, so Equillium's price volatility has been higher than the market average.
| Beta (5Y) | 1.80 |
| 52-Week Price Change | +15.95% |
| 50-Day Moving Average | 2.35 |
| 200-Day Moving Average | 2.04 |
| Relative Strength Index (RSI) | 36.98 |
| Average Volume (20 Days) | 428,545 |
Short Selling Information
The latest short interest is 5.37 million, so 8.47% of the outstanding shares have been sold short.
| Short Interest | 5.37M |
| Short Previous Month | 5.53M |
| Short % of Shares Out | 8.47% |
| Short % of Float | 14.53% |
| Short Ratio (days to cover) | 10.86 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -19.30M |
| Pretax Income | -18.01M |
| Net Income | -18.01M |
| EBITDA | -19.20M |
| EBIT | -19.30M |
| Earnings Per Share (EPS) | -$0.20 |
Balance Sheet
The company has $57.16 million in cash and $584,000 in debt, with a net cash position of $56.58 million or $0.89 per share.
| Cash & Cash Equivalents | 57.16M |
| Total Debt | 584,000 |
| Net Cash | 56.58M |
| Net Cash Per Share | $0.89 |
| Equity (Book Value) | 56.02M |
| Book Value Per Share | 0.88 |
| Working Capital | 55.50M |
Cash Flow
In the last 12 months, operating cash flow was -$19.97 million and capital expenditures -$118,000, giving a free cash flow of -$20.09 million.
| Operating Cash Flow | -19.97M |
| Capital Expenditures | -118,000 |
| Depreciation & Amortization | 101,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -20.09M |
| FCF Per Share | -$0.32 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Equillium does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -157.46% |
| Shareholder Yield | -157.46% |
| Earnings Yield | -15.07% |
| FCF Yield | -16.81% |
Analyst Forecast
The average price target for Equillium is $8.56, which is 352.91% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.56 |
| Price Target Difference | 352.91% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |